Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|January 7, 2006
Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter regionChristina A Ortmann, Andreas Burchert, Katharina Hölzle, et al.
Haematologica|May 4, 2006
TERC mutations in children with refractory cytopeniaChristina A Ortmann, Charlotte M Niemeyer, Angela Wawer, et al.
Annals of Hematology|July 1, 2008
Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemiaChristina A Ortmann, Lewin Eisele, Holger Nückel, et al.
Blood|May 13, 2011
Effects of the JAK2 mutation on the hematopoietic stem and progenitor compartment in human myeloproliferative neoplasmsShubha Anand, Frances Stedham, Philip Beer, et al.
Haematologica|September 9, 2010
Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasmsPhilip A Beer, Christina A Ortmann, Frank Stegelmann, et al.
Cancer Cell|November 16, 2010
Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signalingEdwin Chen, Philip A Beer, Anna L Godfrey, et al.
JAMA Cardiology|December 20, 2018
Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart FailureLena Dorsheimer, Birgit Assmus, Tina Rasper, et al.
Cell Reports|May 16, 2019
Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous TransplantationChristina A Ortmann, Lena Dorsheimer, Khalil Abou-El-Ardat, et al.
Blood|January 13, 2011
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutationsFrancesco Passamonti, Chiara Elena, Susanne Schnittger, et al.
Blood|August 18, 2012
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subcloneAnna L Godfrey, Edwin Chen, Francesca Pagano, et al.
Pageof 2